Among people who inject drugs (PWID) in the US, successful hepatitis C virus (HCV) treatment as prevention should incorporate the baseline HCV and will achieve the greatest benefit when coverage is expanded, a recent study found. Five graph models were fit using data from 1,574 PWID in Hartford, CT. Researchers simulated transmission of HCV and HIV through this network with varying levels of HCV treatment coverage and varying baseline HCV prevalence in PWID. They then compared the effectiveness of 7 treatment-as-prevention strategies on reducing HCV prevalence over 10 years and 20 years vs no treatment. They found:
- At the highest baseline HCV prevalence in PWID (85%), expansion of treatment does not substantially reduce HCV prevalence for any treatment-as-prevention strategy.
- However, when baseline HCV prevalence is ≤60%, treating >120 (12%) individuals per 1,000 PWID per year would likely eliminate HCV within 10 years.
- On average, assigning treatment randomly to individuals who inject drugs is better than targeting individuals with the most injection partners.
Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: A modelling study. Lancet. 2018;18(2):215-224. doi:10.1016/S1473-3099(17)30676-X.
This Week's Must Reads
ED Visits for ADEs From Antibiotics in Children, J Pediatric Infect Dis Soc; ePub 2018 Aug 23; Lovegrove, et al
Food Insecurity & Inflammation in Women Living with HIV, J Infect Dis; ePub 2018 Aug 27; Leddy, et al
Racial and Ethnic Disparities in HIV Care, Clin Infect Dis; ePub 2018 Aug 31; Desir, et al
Outcomes of Community & Hospital-Onset CDI, Clin Infect Dis; ePub 2018 Aug 23; Pinzon, et al
MRSA Infections After Hospital Discharge, Clin Infect Dis; ePub 2018 Aug 11; Nelson, et al
Must Reads in Hepatitis
Mortality in US Patients with Chronic HBV, Clin Infect Dis; ePub 2018 Jul 28; Bixler, et al
Pregnancy Outcomes in Women with HBV , Open Forum Infect Dis; ePub 2018 Jun 9; Bajema, et al
HBV Prevention in Foreign-Born Women, Clin Infect Dis; ePub 2018 Jun 1; Kilmer, et al
ACIP Recommends Hepatitis B Vaccine for Adults, MMWR; 2018 Apr 20; Schillie, Harris, et al
HCV Treatment as Prevention in PWIDs, Lancet; 2018 Feb; Zelenev, Li, et al